Abstract
The family Flaviviridae consists of four genera, Flavivirus, Pestivirus, Pegivirus, and Hepacivirus, and comprises important pathogens of human and animals. Although the construction of recombinant viruses carrying reporter genes encoding fluorescent and bioluminescent proteins has been reported, the stable insertion of foreign genes into viral genomes retaining infectivity remains difficult. Here, we applied the 11-amino-acid subunit derived from NanoLuc luciferase to the engineering of the Flaviviridae viruses and then examined the biological characteristics of the viruses. We successfully generated recombinant viruses carrying the split-luciferase gene, including dengue virus, Japanese encephalitis virus, hepatitis C virus (HCV), and bovine viral diarrhea virus. The stability of the viruses was confirmed by five rounds of serial passages in the respective susceptible cell lines. The propagation of the recombinant luciferase viruses in each cell line was comparable to that of the parental viruses. By using a purified counterpart luciferase protein, this split-luciferase assay can be applicable in various cell lines, even when it is difficult to transduce the counterpart gene. The efficacy of antiviral reagents against the recombinant viruses could be monitored by the reduction of luciferase expression, which was correlated with that of viral RNA, and the recombinant HCV was also useful to examine viral dynamics in vivo. Taken together, our findings indicate that the recombinant Flaviviridae viruses possessing the split NanoLuc luciferase gene generated here provide powerful tools to understand viral life cycle and pathogenesis and a robust platform to develop novel antivirals against Flaviviridae viruses.
| Original language | English |
|---|---|
| Article number | e01582-17 |
| Journal | Journal of Virology |
| Volume | 92 |
| Issue number | 2 |
| ISSN | 0022-538X |
| DOIs | |
| Publication status | Published - 02.01.2018 |
Funding
This work was supported in part by grants-in-aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Science, Sports, and Technology (MEXT; http://www.mext.go.jp/) of Japan (16H06429, 16K21723, and 16H06432) and for Scientific Research (B) from MEXT of Japan (15H04736), from the Ministry of Health, Labor and Welfare of Japan and the Japan Agency for Medical Research and Development (AMED; http://www.amed.go.jp/) Research Program on Hepatitis, 17fk0210106h0002 and 16fk0310515h0105, and Research Program on Emerging and Reemerging Infectious Diseases, 17fk0108109h0001, and from the JSPS KAKENHI (https://www.jsps.go.jp/english/e-grants/), grant number 16J02628. T. Tamura is supported by a JSPS Research Fellowships for young scientists (https://www.jsps.go.jp/ english/e-grants/). We have no conflicts of interest to declare.
Research Areas and Centers
- Academic Focus: Center for Infection and Inflammation Research (ZIEL)
DFG Research Classification Scheme
- 2.21-04 Virology